SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 245-249

  Zhang, Xin Lin ^a   Zhang, Cheng Wei ^a   Xu, Pei ^a   Liang, Feng Jing ^a   Che, Ye Na ^a   Xia, Yan Jie ^a   Cao, Yun Xia ^b   Wu, Xiao Ke ^c   Wang, Wen Jun ^d   Yi, Long ^a   Gao, Qian ^a   Wang, Yong ^a  

^a NANJING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aromatase activity; CYP19; Polycystic ovary syndrome; Rs2470152; Single nucleotide polymorphism

Indexed keywords

AROMATASE; ESTRADIOL; TESTOSTERONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL;

ADULT; ALLELES; AROMATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ESTRADIOL; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TESTOSTERONE;

EID: 84855252913     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.616     Document Type: Article

References (23)

1. Wood JR, Nelson VL, Ho C, et al.: The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278: 26380-26390, 2003. (Pubitemid 36876777)
2. Azziz R, Carmina E, Dewailly D, et al.: Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237-4245, 2006. (Pubitemid 44833391)
3. Diamanti-Kandarakis E: Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Exp Rev Mol Med 10: e3, 2008.
4. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18: 774-800, 1997.
5. Yildiz BO, Yarali H, Oguz H and Bayraktar M: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 2031-2036, 2003. (Pubitemid 36549872)
6. Williamson K, Gunn AJ, Johnson N and Milsom SR: The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust N Z J Obstet Gynaecol 41: 202-206, 2001. (Pubitemid 32515023)
7. Jakimiuk AJ, Weitsman SR, Brzechffa PR and Magoffin DA: Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 4: 1-8, 1998. (Pubitemid 28109154)
8. Jin JL, Sun J, Ge HJ, et al.: Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med Genet 10: 139, 2009.
9. Gharani N, Waterworth DM, Batty S, et al.: Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6: 397-402, 1997. (Pubitemid 27116459)
10. Carey AH, Waterworth D, Patel K, et al.: Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3: 1873-1876, 1994. (Pubitemid 24310487)
11. Jones MR, Italiano L, Wilson SG, et al.: Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 86: 1438-1446, 2006. (Pubitemid 44602053)
12. Ferk P, Perme MP and Gersak K: Insulin gene polymorphism in women with polycystic ovary syndrome. J Int Med Res 36: 1180-1187, 2008.
13. Xu P, Che Y, Cao Y, et al.: Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. J Assist Reprod Genet 27: 23-28, 2010.
14. Chen SA, Besman MJ, Sparkes RS, et al.: Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA 7: 27-38, 1988. (Pubitemid 18044631)
15. Harada N, Ogawa H, Shozu M and Yamada K: Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet 51: 666-672, 1992.
16. Eriksson AL, Lorentzon M, Vandenput L, et al.: Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94: 1033-1041, 2009.
17. Jiang J, Tang NL, Ohlsson C, et al.: Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men. Clin Chim Acta 411: 53-58, 2010.
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25, 2004.
19. Sun J, Fan H, Che Y, et al.: Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. BMC Med Genet 10: 64, 2009.
20. Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B and Sebastian S: Organization of the human aromatase p450 (CYP19) gene. Sem Reprod Med 22: 5-9, 2004. (Pubitemid 38524579)
21. Wang H, Li Q, Wang T, et al.: A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro. Mol Hum Reprod 17: 386-391, 2011.
22. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H and Shozu M: The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Ster Biochem Mol Biol 86: 219-224, 2003. (Pubitemid 37412560)
23. Sofi M, Young MJ, Papamakarios T, Simpson ER and Clyne CD: Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res Treat 79: 399-407, 2003. (Pubitemid 36750947)